Petaluma, Calif. -- Tegal, a Petaluma-based developer of emerging technologies in medical devices and health care, said on Monday it has acquired CollabRx, a Palo Alto-based developer of interpretive content and data analytics tools used in genomics-based medicine. Under the deal, Tegal will issue about 236,000 shares, representing 14% of its total stake. The CEOs of the two companies, Thomas Mika of Tegal and James Karis of CollabRx, will serve as co-CEOs of the combined, publicly traded company, which will operate under the CollabRx name with headquarters in San Francisco. The companies first announced plans for the deal in early July.
http://www.tegal.com
http://www.tegal.com/news/press-releases/83-tegal-news/press-releases-2011/232-tegal-corporation-closes-acquisition-of-collabrx-inc-and-reports-inducement-grants-under-nasdaq-listing-rule-5635c4